相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease
Marta Gonzalez-Sepulveda et al.
BRAIN (2023)
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease
Anna Masato et al.
NPJ PARKINSONS DISEASE (2023)
Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish
Diego Baronio et al.
ACTA PHYSIOLOGICA (2022)
Prevalence of ten LRRK2 variants in Parkinson's disease: A comprehensive review
Christopher Simpson et al.
PARKINSONISM & RELATED DISORDERS (2022)
A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
Vignayanandam Ravindernath-Jayashree Muddapu et al.
FRONTIERS IN NEUROSCIENCE (2022)
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
Zhi Dong Zhou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage
Philipp Hoermann et al.
CELL DEATH DISCOVERY (2021)
Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects
Max Borsche et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Zinc antagonizes iron-regulation of tyrosine hydroxylase activity and dopamine production in Drosophila melanogaster
Guiran Xiao et al.
BMC BIOLOGY (2021)
Dopamine in Parkinson's disease
Saad Latif et al.
CLINICA CHIMICA ACTA (2021)
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
Jacqueline M. Tokarew et al.
ACTA NEUROPATHOLOGICA (2021)
Mitochondrial Function and Parkinson's Disease: From the Perspective of the Electron Transport Chain
Jeng-Lin Li et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27
Junna Hayashi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo
Laura M. Vecchio et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Alpha-Synuclein Aggregation in Parkinson's Disease
E. Srinivasan et al.
FRONTIERS IN MEDICINE (2021)
Liquid-liquid phase separation and self-assembly of a lysine derivative Fmoc-L-lysine in water-DMSO mixtures
Nikesh Narang et al.
POLYMER JOURNAL (2021)
DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65
Zixuan Lin et al.
CELL DEATH & DISEASE (2021)
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson's Disease
Youcui Wang et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
An Update on Medical and Surgical Treatments of Parkinson's Disease
Dipali Nemade et al.
AGING AND DISEASE (2021)
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein
Yunden Jinsmaa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
The Oxidative Pathway to Dopamine-Protein Conjugates and Their Pro-Oxidant Activities: Implications for the Neurodegeneration of Parkinson's Disease
Kazumasa Wakamatsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Daniel A. Monti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Impaired dopamine metabolism in Parkinson's disease pathogenesis
Anna Masato et al.
MOLECULAR NEURODEGENERATION (2019)
DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives
Mariaelena Repici et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD)
Zhi Dong Zhou et al.
CELLS (2019)
The modulatory role of dopamine receptors in brain neuroinflammation
Qing-Peng Xia et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease
Lena F. Burbulla et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration
Shun Zhang et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration
Danielle E. Mor et al.
MOVEMENT DISORDERS (2019)
Rab GTPases as Physiological Substrates of LRRK2 Kinase
Wongi Seol et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling
Rainer Knoerle
NEUROTOXICITY RESEARCH (2018)
Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson's Disease
Alice Biosa et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages
Stefanie Dichtl et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein
Jonathan W. Werner-Allen et al.
BIOCHEMISTRY (2018)
3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine
Yunden Jinsmaa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease
Maria Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Insights into the structural biology of Gaucher disease
Laura Smith et al.
EXPERIMENTAL NEUROLOGY (2017)
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
Danielle E. Mor et al.
NATURE NEUROSCIENCE (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N. Plotegher et al.
SCIENTIFIC REPORTS (2017)
Structure of PINK1 and mechanisms of Parkinson's disease-associated mutations
Atul Kumar et al.
ELIFE (2017)
Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde
Brigitte C. Vanle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures
Antonio Dominguez-Meijide et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin
Nicoletta Plotegher et al.
AGEING RESEARCH REVIEWS (2016)
Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
Jon W. Werner-Allen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite
David G. Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2016)
Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons
Jillienne C. Touchette et al.
NEUROSCIENCE LETTERS (2016)
Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease
Lu Gao et al.
PLOS ONE (2016)
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity
Kelly M. Lohr et al.
ACS CHEMICAL NEUROSCIENCE (2015)
In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra
Guohua Yu et al.
EXPERIMENTAL NEUROLOGY (2015)
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
Cristian Follmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies
Davide Chiasserini et al.
MOLECULAR NEURODEGENERATION (2015)
Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits
S. T. Masoud et al.
NEUROBIOLOGY OF DISEASE (2015)
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German et al.
PHARMACOLOGICAL REVIEWS (2015)
Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
Zhi Dong Zhou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Structural Basis for the Site-Specific Incorporation of Lysine Derivatives into Proteins
Veronika Fluegel et al.
PLOS ONE (2014)
Glucocerebrosidase mutations and the pathogenesis of Parkinson disease
Michelle S. Beavan et al.
ANNALS OF MEDICINE (2013)
Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4
David N. Hauser et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis
Emanuele Ferrari et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
David J. Irwin et al.
NATURE REVIEWS NEUROSCIENCE (2013)
DECREASED PARKIN SOLUBILITY IS ASSOCIATED WITH IMPAIRMENT OF AUTOPHAGY IN THE NIGROSTRIATUM OF SPORADIC PARKINSON'S DISEASE
I. Lonskaya et al.
NEUROSCIENCE (2013)
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
Arthur G. Fitzmaurice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The GTPase function of LRRK2
Jean-Marc Taymans
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Protective Effects of L-Dopa and Carbidopa Combined Treatments on Human Catecholaminergic Cells
Monica Colamartino et al.
DNA AND CELL BIOLOGY (2012)
L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro
Sandra W. Chan et al.
EXPERIMENTAL NEUROLOGY (2012)
Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53
Stefania Girotto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Neuromelanin enhances the toxicity of α-synuclein in SK-N-SH cells
Jie Li et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
The link between the GBA gene and parkinsonism
Ellen Sidransky et al.
LANCET NEUROLOGY (2012)
Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
Margaret Chia-Ying Wey et al.
PLOS ONE (2012)
Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease
Elisa Belluzzi et al.
PLOS ONE (2012)
Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease
Sirsendu Jana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
A. Napolitano et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone
David G. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP plus ) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade
W. Michael Zawada et al.
JOURNAL OF NEUROINFLAMMATION (2011)
MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress
Ya-Ching Hsieh et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y Cells
Na Wang et al.
NEUROCHEMICAL RESEARCH (2011)
Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
Lydia M. Mexas et al.
NEUROTOXICOLOGY (2011)
Dopamine quinones interact with a-synuclein to form unstructured adducts
Marco Bisaglia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
Marco Bisaglia et al.
BMC NEUROSCIENCE (2010)
Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise Implications for iron-related dopaminergic neuron degeneration
Zhi Dong Zhou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients
Aleksandar Rakovic et al.
HUMAN MOLECULAR GENETICS (2010)
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Yanqi Chang et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease
Florian Bayersdorfer et al.
NEUROBIOLOGY OF DISEASE (2010)
Glutathione Conjugates with Dopamine-Derived Quinones to Form Reactive or Non-Reactive Glutathione-Conjugates
Zhi Dong Zhou et al.
NEUROCHEMICAL RESEARCH (2010)
Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line
Irmgard Paris et al.
NEUROTOXICITY RESEARCH (2010)
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
W. Michael Panneton et al.
PLOS ONE (2010)
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Mitochondrial dynamics in Parkinson's disease
Victor S. Van Laar et al.
EXPERIMENTAL NEUROLOGY (2009)
Glutathione-a review on its role and significance in Parkinson's disease
Heather L. Martin et al.
FASEB JOURNAL (2009)
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones
Zhi Dong Zhou et al.
FREE RADICAL RESEARCH (2009)
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease
Teresa G. Hastings
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
DJ-1 protects against dopamine toxicity
Nirit Lev et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Microglial responses to dopamine in a cell culture model of Parkinson's disease
Diego Mastroeni et al.
NEUROBIOLOGY OF AGING (2009)
Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells
Victor S. Van Laar et al.
NEUROBIOLOGY OF DISEASE (2009)
Roles of Glutathione (GSH) in Dopamine (DA) Oxidation Studied by Improved Tandem HPLC Plus ESI-MS
Zhi Dong Zhou et al.
NEUROCHEMICAL RESEARCH (2009)
Approaches to Prevent Dopamine Quinone-Induced Neurotoxicity
Ikuko Miyazaki et al.
NEUROCHEMICAL RESEARCH (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons:: Protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide
Zhenquan Jia et al.
BRAIN RESEARCH (2008)
Myoglobin Modification by Enzyme-Generated Dopamine Reactive Species
Stefania Nicolis et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
3-Methoxytyramine, an extraneuronal dopamine metabolite plays a physiological role in the brain as an inhibitory regulator of catecholaminergic activity
Lucyna Antkiewicz-Michaluk et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Oxidative and nitrative protein modifications in Parkinson's disease
Steven R. Danielson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132
Zhidong Zhou et al.
FREE RADICAL RESEARCH (2008)
Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis
Thomas S. Guillot et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Linan Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
The Lewy body in Parkinson's disease:: Molecules implicated in the formation and degradation of α-synuclein aggregates
Koichi Wakabayashi et al.
NEUROPATHOLOGY (2007)
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: The role of aldehyde dehydrogenase
Satori A. Marchitti et al.
PHARMACOLOGICAL REVIEWS (2007)
Kinetic and structural analysis of the early oxidation products of dopamine -: Analysis of the interactions with α-synuclein
Marco Bisaglia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts
Shalom Michaeli et al.
MOVEMENT DISORDERS (2007)
L-DOPA administration enhances 6-hydroxydopamine generation
H Maharaj et al.
BRAIN RESEARCH (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dopamine covalently modifies and functionally inactivates parkin
MJ LaVoie et al.
NATURE MEDICINE (2005)
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway
J Lotharius et al.
JOURNAL OF NEUROSCIENCE (2005)
Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway
R Cappai et al.
FASEB JOURNAL (2005)
Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant α-synuclein
ZD Zhou et al.
EXPERIMENTAL CELL RESEARCH (2005)
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
RM Canet-Avilés et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Interactions among alpha-synuclein, dopamine, and biomembranes - Some clues for understanding neurodegeneration in Parkinson's disease
JC Rochet et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis
WJ Burke et al.
BRAIN RESEARCH (2003)
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease
M Asanuma et al.
NEUROTOXICITY RESEARCH (2003)
Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra
G Díaz-Véliz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
KA Conway et al.
SCIENCE (2001)
Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases
MM Banaclocha
MEDICAL HYPOTHESES (2001)
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
RE Whitehead et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation - A novel mechanism of toxicity
J Lotharius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine
AD Rabinovic et al.
NEUROSCIENCE (2000)
分享论文
